IMMX
NASDAQ · Biotechnology
Immix Biopharma Inc
$7.32
+0.12 (+1.67%)
Performance
1D
—
1W
-4.69%
1M
-22.87%
3M
-27.74%
6M
-26.21%
1Y
+141.58%
YTD
+34.81%
Open$7.27
Previous Close$7.20
Day High$7.45
Day Low$7.16
52W High$15.10
52W Low$2.85
Volume—
Avg Volume1.22M
Market Cap636.69M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$10.65
Below
SMA 200
$9.53
Below
RSI (14)
41.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
13 analysts
Price Target
+63.7% upside
Current
$7.32
$7.32
Target
$11.98
$11.98
$7.05
$11.98 avg
$14.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 163.82M | 157.27M | 158.27M |
| Net Income | -44,702,535 | -44,556,024 | -43,506,106 |
| Profit Margin | -27.3% | -28.3% | -27.5% |
| EBITDA | -45,867,623 | -43,115,764 | -48,402,369 |
| Free Cash Flow | -22,695,190 | -23,234,474 | -24,663,069 |
| Rev Growth | +3.0% | +15.0% | +13.1% |
| Debt/Equity | 0.40 | 0.42 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |